Related references
Note: Only part of the references are listed.The dual role of DNA repair protein MGMT in cancer prevention and treatment
Peiying Bai et al.
DNA REPAIR (2023)
Pharmacological inhibition of serine synthesis enhances temozolomide efficacy by decreasing O6-methylguanine DNA methyltransferase (MGMT) expression and reactive oxygen species (ROS)-mediated DNA damage in glioblastoma
Lei Jin et al.
LABORATORY INVESTIGATION (2022)
Dexamethasone Attenuates Oncostatin M Production via Suppressing of PI3K/Akt/NF-κB Signaling in Neutrophil-like Differentiated HL-60 Cells
Na-Ra Han et al.
MOLECULES (2022)
Novel Repositioning Therapy for Drug-Resistant Glioblastoma: In Vivo Validation Study of Clindamycin Treatment Targeting the mTOR Pathway and Combination Therapy with Temozolomide
Takeyoshi Eda et al.
CANCERS (2022)
LncRNA UCA1/miR-182-5p/MGMT axis modulates glioma cell sensitivity to temozolomide through MGMT-related DNA damage pathways
Meixiong Cheng et al.
HUMAN PATHOLOGY (2022)
Tubeimoside-I sensitizes temozolomide-resistant glioblastoma cells to chemotherapy by reducing MGMT expression and suppressing EGFR induced PI3K/Akt/mTOR/NF-κB-mediated signaling pathway
Qingfa Tang et al.
PHYTOMEDICINE (2022)
Cyanidin-3-O-glucoside inhibits the β-catenin/MGMT pathway by upregulating miR-214-5p to reverse chemotherapy resistance in glioma cells
Yuan Zhou et al.
SCIENTIFIC REPORTS (2022)
Mannose inhibits proliferation and promotes apoptosis to enhance sensitivity of glioma cells to temozolomide through Wnt/β-catenin signaling pathway
Yan-Qing Fei et al.
NEUROCHEMISTRY INTERNATIONAL (2022)
Emerging roles of long noncoding RNAs in chemoresistance of pancreatic cancer
Wangkai Xie et al.
SEMINARS IN CANCER BIOLOGY (2022)
Concurrent Dexamethasone Limits the Clinical Benefit of Immune Checkpoint Blockade in Glioblastoma
J. Bryan Iorgulescu et al.
CLINICAL CANCER RESEARCH (2021)
Regulation of temozolomide resistance in glioma cells via the RIP2/NF-κB/MGMT pathway
Yu-Hua Hu et al.
CNS NEUROSCIENCE & THERAPEUTICS (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Pyrvinium pamoate regulates MGMT expression through suppressing the Wnt/β-catenin signaling pathway to enhance the glioblastoma sensitivity to temozolomide
Haisong Li et al.
CELL DEATH DISCOVERY (2021)
Banxia xiexin decoction affects drug sensitivity in gastric cancer cells by regulating MGMT expression via IL-6/JAK/STAT3-mediated PD-L1 activity
Xuan Feng et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2021)
NBM-BMX, an HDAC8 Inhibitor, Overcomes Temozolomide Resistance in Glioblastoma Multiforme by Downregulating the beta-Cateninic-Myc/SOX2 Pathway and Upregulating p53-Mediated MGMT Inhibition
Cheng-Yu Tsai et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastoma
G. Guo et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2020)
A steroidal saponin form Paris vietnamensis (Takht.) reverses temozolomide resistance in glioblastoma cells via inducing apoptosis through ROS/PI3K/Akt pathway
Shan Zhang et al.
BIOSCIENCE TRENDS (2020)
Biomarker-Guided Development of DNA Repair Inhibitors
James M. Cleary et al.
MOLECULAR CELL (2020)
MGMT expression affects the gemcitabine resistance of pancreatic cancer cells
Yu Shi et al.
LIFE SCIENCES (2020)
Combination of levetiracetam and IFN-α increased temozolomide efficacy in MGMT-positive glioma
Xiang-Rong Ni et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2020)
Correlation of genetic alterations by whole-exome sequencing with clinical outcomes of glioblastoma patients from the Lebanese population
Fadi S. Saadeh et al.
PLOS ONE (2020)
Blocking MAPK/ERK pathway sensitizes hepatocellular carcinoma cells to temozolomide via downregulating MGMT expression
Qiang Li et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
Dexamethasone inhibits BMP7-induced osteogenic differentiation in rat dental follicle cells via the PI3K/AKT/GSK-3β/β-catenin pathway
Jing Tang et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2020)
Olanzapine induced autophagy through suppression of NF-κB activation in human glioma cells
Ying Zhu et al.
CNS NEUROSCIENCE & THERAPEUTICS (2019)
DNA repair in personalized brain cancer therapy with temozolomide and nitrosoureas
Bernd Kaina et al.
DNA REPAIR (2019)
Lnc-TALC promotes O6-methylguanine-DNA methyltransferase expression via regulating the c-Met pathway by competitively binding with miR-20b-3p
Pengfei Wu et al.
NATURE COMMUNICATIONS (2019)
Polyphyllin VII Promotes Apoptosis and Autophagic Cell Death via ROS-Inhibited AKT Activity, and Sensitizes Glioma Cells to Temozolomide
Dejiang Pang et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
MicroRNAs Involved in Carcinogenesis, Prognosis, Therapeutic Resistance, and Applications in Human Triple-Negative Breast Cancer
Lei Ding et al.
CELLS (2019)
Cortistatin exerts antiproliferation and antimigration effects in vascular smooth muscle cells stimulated by Ang II through suppressing ERK1/2, p38 MAPK, JNK and ERK5 signaling pathways
Ying Wang et al.
ANNALS OF TRANSLATIONAL MEDICINE (2019)
20(S)-ginsenoside-Rg3 reverses temozolomide resistance and restrains epithelial-mesenchymal transition progression in glioblastoma
Zheng Chen et al.
CANCER SCIENCE (2019)
The potential role of tubeimosides in cancer prevention and treatment
Md Sodrul Islam et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Resveratrol restores sensitivity of glioma cells to temozolamide through inhibiting the activation of Wnt signaling pathway
Hua-Chao Yang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Fstl1/DIP2A/MGMT signaling pathway plays important roles in temozolomide resistance in glioblastoma
Er Nie et al.
ONCOGENE (2019)
MiR-21, miR-34a, miR-125b, miR-181d and miR-648 levels inversely correlate with MGMT and TP53 expression in primary glioblastoma patients
Dorota Jesionek-Kupnicka et al.
ARCHIVES OF MEDICAL SCIENCE (2019)
The miR-26a/AP-2 alpha/Nanog signaling axis mediates stem cell self-renewal and temozolomide resistance in glioma
Wenhuan Huang et al.
THERANOSTICS (2019)
Glucocorticoids promote a glioma stem cell-like phenotype and resistance to chemotherapy in human glioblastoma primary cells: Biological and prognostic significance
Ourania N. Kostopoulou et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
The novel role of pyrvinium in cancer therapy
Amir A. Momtazi-borojeni et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Novel approach to temozolomide resistance in malignant glioma: connexin43-directed therapeutics
Christina L. Grek et al.
CURRENT OPINION IN PHARMACOLOGY (2018)
Peroxynitrite enhances self-renewal, proliferation and neuronal differentiation of neural stem/progenitor cells through activating HIF-1α and Wnt/β-catenin signaling pathway
Xingmiao Chen et al.
FREE RADICAL BIOLOGY AND MEDICINE (2018)
The specific role of O-6-methylguanine-DNA methyltransferase inhibitors in cancer chemotherapy
Guohui Sun et al.
FUTURE MEDICINAL CHEMISTRY (2018)
New Steroidal Saponins from the Rhizomes of Paris vietnamensis and Their Cytotoxicity
Yang Liu et al.
MOLECULES (2018)
Current state of immunotherapy for glioblastoma
Michael Lim et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
CAT3, a prodrug of 13a(S)-3-hydroxyl-6,7-dimethoxyphenanthro[9, 10-b]-indolizidine, circumvents temozolomide-resistant glioblastoma via the Hedgehog signaling pathway, independently of O6-methylguanine DNA methyltransferase expression
Ming Ji et al.
ONCOTARGETS AND THERAPY (2018)
Long noncoding RNA MALAT1 knockdown reverses chemoresistance to temozolomide via promoting microRNA-101 in glioblastoma
Tao Cai et al.
CANCER MEDICINE (2018)
FM19G11 inhibits O6-methylguanine DNA-methyltransferase expression under both hypoxic and normoxic conditions
Chao-guo You et al.
CANCER MEDICINE (2018)
β-catenin contributes to cordycepin-induced MGMT inhibition and reduction of temozolomide resistance in glioma cells by increasing intracellular reactive oxygen species
Yiming Bi et al.
CANCER LETTERS (2018)
TGF-/βSmads Signaling Affects Radiation Response and Prolongs Survival by Regulating DNA Repair Genes in Malignant Glioma
Sichen Tao et al.
DNA AND CELL BIOLOGY (2018)
Targeting Tumor Metabolism with Plant-Derived Natural Products: Emerging Trends in Cancer Therapy
Angela R. Guerra et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2018)
Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma
Shabierjiang Jiapaer et al.
NEUROLOGIA MEDICO-CHIRURGICA (2018)
Natural products for the prevention and treatment of kidney disease
Dan-Qian Chen et al.
PHYTOMEDICINE (2018)
Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancer
Alex H. Wagner et al.
NATURE COMMUNICATIONS (2018)
Epigallocatechin Gallate Preferentially Inhibits O6-Methylguanine DNA-Methyltransferase Expression in Glioblastoma Cells Rather than in Nontumor Glial Cells
Chao-Ran Xie et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2018)
Structural basis of RIP2 activation and signaling
Qin Gong et al.
NATURE COMMUNICATIONS (2018)
Dexamethasone and Fludrocortisone Inhibit Hedgehog Signaling in Embryonic Cells
Kirti Kandhwal Chahal et al.
ACS OMEGA (2018)
Resveratrol as an anti-cancer agent: A review
Abdur Rauf et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2018)
The potential of combi-molecules with DNA-damaging function as anticancer agents
Guohui Sun et al.
FUTURE MEDICINAL CHEMISTRY (2017)
Tanshinone IIA induces apoptosis via inhibition of Wnt/β-catenin/MGMT signaling in AtT-20 cells
Zong-Yang Li et al.
MOLECULAR MEDICINE REPORTS (2017)
Diagnostic and Therapeutic Biomarkers in Glioblastoma: Current Status and Future Perspectives
Wojciech Szopa et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Gene and protein expressions and metabolomics exhibit activated redox signaling and wnt/β-catenin pathway are associated with metabolite dysfunction in patients with chronic kidney disease
Dan-Qian Chen et al.
REDOX BIOLOGY (2017)
The Hedgehog Signaling Pathway Emerges as a Pathogenic Target
Margery G. Smelkinson
JOURNAL OF DEVELOPMENTAL BIOLOGY (2017)
The Induction and Repair of DNA Interstrand Crosslinks and Implications in Cancer Chemotherapy
Sun Guohui et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2016)
Sulforaphane reverses chemo-resistance to temozolomide in glioblastoma cells by NF-κB-dependent pathway downregulating MGMT expression
Fengming Lan et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
CAT3, a novel agent for medulloblastoma and glioblastoma treatment, inhibits tumor growth by disrupting the Hedgehog signaling pathway
Ju Chen et al.
CANCER LETTERS (2016)
GANT61, a GLI inhibitor, sensitizes glioma cells to the temozolomide treatment
Jianlong Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
High Expression of PHGDH Predicts Poor Prognosis in Non-Small Cell Lung Cancer
Jinhong Zhu et al.
TRANSLATIONAL ONCOLOGY (2016)
Natural Products as a Source for Novel Antibiotics
Mark G. Moloney
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
Helicobacter pylori CagA induces tumor suppressor gene hypermethylation by upregulating DNMT1 via AKT-NFκB pathway in gastric cancer development
Bao-gui Zhang et al.
ONCOTARGET (2016)
Up-regulation of miR-370-3p restores glioblastoma multiforme sensitivity to temozolomide by influencing MGMT expression
Yong-tao Gao et al.
SCIENTIFIC REPORTS (2016)
BACH1 Promotes Temozolomide Resistance in Glioblastoma through Antagonizing the Function of p53
Er Nie et al.
SCIENTIFIC REPORTS (2016)
The efficacy of levetiracetam for patients with supratentorial brain tumors
Yang Yuan et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2015)
Interferon-α/β enhances temozolomide activity against MGMT-positive glioma stem-like cells
Dong Shen et al.
ONCOLOGY REPORTS (2015)
Anti-lung Cancer Effects of Polyphyllin VI and VII Potentially Correlate with Apoptosis In Vitro and In Vivo
Zhufen Lin et al.
PHYTOTHERAPY RESEARCH (2015)
NF-κB inhibitor reverses temozolomide resistance in human glioma TR/U251 cells
Xuan Wang et al.
ONCOLOGY LETTERS (2015)
Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance
Malin Wickstrom et al.
NATURE COMMUNICATIONS (2015)
TRIM24 promotes glioma progression and enhances chemoresistance through activation of the PI3K/Akt signaling pathway
L-H Zhang et al.
ONCOGENE (2015)
Anti-angiogenic effect of tanshinone IIA involves inhibition of the VEGF/VEGFR2 pathway in vascular endothelial cells
Yingying Xing et al.
ONCOLOGY REPORTS (2015)
The Synergistic Effect of Combination Progesterone and Temozolomide on Human Glioblastoma Cells
Fahim Atif et al.
PLOS ONE (2015)
Autophagy Involvement in Olanzapine-Mediated Cytotoxic Effects in Human Glioma Cells
Yi-Xuan Wang et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Dual mTORC1/2 Blockade Inhibits Glioblastoma Brain Tumor Initiating Cells In Vitro and In Vivo and Synergizes with Temozolomide to Increase Orthotopic Xenograft Survival
H. Artee Luchman et al.
CLINICAL CANCER RESEARCH (2014)
Use of dexamethasone in patients with high-grade glioma: a clinical practice guideline
X. Kostaras et al.
CURRENT ONCOLOGY (2014)
Olanzapine for the prevention and treatment of chronic nausea and chemotherapy-induced nausea and vomiting
Rudolph M. Navari
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
The IL-6/JAK/STAT3 pathway: Potential therapeutic strategies in treating colorectal cancer (Review)
Shu-Wei Wang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Oxidative cytotoxic agent withaferin A resensitizes temozolomide-resistant glioblastomas via MGMT depletion and induces apoptosis through Akt/mTOR pathway inhibitory modulation
Patrick T. Grogan et al.
INVESTIGATIONAL NEW DRUGS (2014)
mTOR inhibition and levels of the DNA repair protein MGMT in T98G glioblastoma cells
Sarah Smalley et al.
MOLECULAR CANCER (2014)
Targeting RAS-ERK signalling in cancer: promises and challenges
Ahmed A. Samatar et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Can we safely target the WNT pathway?
Michael Kahn
NATURE REVIEWS DRUG DISCOVERY (2014)
mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy
Markus Weiler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Serine and glycine metabolism in cancer
Ivano Amelio et al.
TRENDS IN BIOCHEMICAL SCIENCES (2014)
Treatment of gastric cancer
Michele Orditura et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Erasers of Histone Acetylation: The Histone Deacetylase Enzymes
Edward Seto et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2014)
Understanding and Targeting Alkylator Resistance in Glioblastoma
Wolfgang Wick et al.
CANCER DISCOVERY (2014)
In human glioblastomas transcript elongation by alternative polyadenylation and miRNA targeting is a potent mechanism of MGMT silencing
Simone Kreth et al.
ACTA NEUROPATHOLOGICA (2013)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
Bortezomib Downregulates MGMT Expression in T98G Glioblastoma Cells
Panagiotis J. Vlachostergios et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2013)
The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance
Florian A. Siebzehnrubl et al.
EMBO MOLECULAR MEDICINE (2013)
Glioblastoma and Other Malignant Gliomas A Clinical Review
Antonio Omuro et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Phosphoglycerate dehydrogenase induces glioma cells proliferation and invasion by stabilizing forkhead box M1
Jinlong Liu et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
miR-221/222 Target the DNA Methyltransferase MGMT in Glioma Cells
Cristina Quintavalle et al.
PLOS ONE (2013)
mTOR Signaling in Growth Control and Disease
Mathieu Laplante et al.
CELL (2012)
Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance
Roel H. Wilting et al.
DRUG RESISTANCE UPDATES (2012)
The sonic hedgehog-GLI1 signaling pathway in brain tumor development
Mehdi H. Shahi et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
Follistatin-related protein/follistatin-like 1 evokes an innate immune response via CD14 and toll-like receptor 4
Kosaku Murakami et al.
FEBS LETTERS (2012)
TGFβ signalling in context
Joan Massague
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
miR-181d: a predictive glioblastoma biomarker that downregulates MGMT expression
Wei Zhang et al.
NEURO-ONCOLOGY (2012)
Multifaceted Roles of Alkyltransferase and Related Proteins in DNA Repair, DNA Damage, Resistance to Chemotherapy, and Research Tools
Anthony E. Pegg
CHEMICAL RESEARCH IN TOXICOLOGY (2011)
Interaction Studies of an Anticancer Alkaloid, (+)-(13aS)-Deoxytylophorinine, with Calf Thymus DNA and Four Repeated Double-Helical DNAs
Zhenjia Liu et al.
CHEMOTHERAPY (2011)
Corticosteroids in brain cancer patients: benefits and pitfalls
Jörg Dietrich et al.
Expert Review of Clinical Pharmacology (2011)
Temozolomide: Mechanisms of Action, Repair and Resistance
Jihong Zhang et al.
Current Molecular Pharmacology (2011)
The TIF1 alpha-related TRIM cofactors couple chromatin modifications to transcriptional regulation, signaling and tumor suppression
Benjamin Herquel et al.
TRANSCRIPTION-AUSTIN (2011)
Targeting O 6-methylguanine-DNA methyltransferase with specific inhibitors as a strategy in cancer therapy
Bernd Kaina et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
Anti-inflammatory effects of cordycepin via suppression of inflammatory mediators in BV2 microglial cells
Jin-Woo Jeong et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2010)
FM19G11, a New Hypoxia-inducible Factor (HIF) Modulator, Affects Stem Cell Differentiation Status
Victoria Moreno-Manzano et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Cordycepin Inhibits Protein Synthesis and Cell Adhesion through Effects on Signal Transduction
Ying Ying Wong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Levetiracetam enhances p53-mediated MGMT inhibition and sensitizes glioblastoma cells to temozolomide
George C. Bobustuc et al.
NEURO-ONCOLOGY (2010)
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
A. Singh et al.
ONCOGENE (2010)
Intratumoral Hypoxic Gradient Drives Stem Cells Distribution and MGMT Expression in Glioblastoma
Francesca Pistollato et al.
STEM CELLS (2010)
Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion
Frederic Varnat et al.
EMBO MOLECULAR MEDICINE (2009)
Defining a role for Sonic hedgehog pathway activation in desmoplastic medulloblastoma by identifying GLI1 target genes
Joon Won Yoon et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Phase II Trial of Temozolomide Plus O6-Benzylguanine in Adults With Recurrent, Temozolomide-Resistant Malignant Glioma
Jennifer A. Quinn et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Cordycepin is an Immunoregulatory Active Ingredient of Cordyceps sinensis
Xiaoxia Zhou et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2008)
The IKK-related kinases: from innate immunity to oncogenesis
Jean-Francois Clement et al.
CELL RESEARCH (2008)
NF-κB and cancer -: identifying targets and mechanisms
Willscott E. Naugler et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2008)
The added value of concurrently administered temozolomide versus adjuvant temozolomide alone in newly diagnosed glioblastoma
David J. Sher et al.
JOURNAL OF NEURO-ONCOLOGY (2008)
Malignant gliomas in adults
Patrick Y. Wen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Novel mechanism whereby nuclear factor κB mediates DNA damage repair through regulation of O6-methylguanine-DNA-methyltransferase
Iris Lavon et al.
CANCER RESEARCH (2007)
DNA binding, nucleotide flipping, and the helix-turn-helix motif in base repair by O6-alkylguanine-DNA alkyltransferase and its implications for cancer chemotherapy
Julie L. Tubbs et al.
DNA REPAIR (2007)
Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast
Brian S. Cornblatt et al.
CARCINOGENESIS (2007)
AKT/PKB signaling: Navigating downstream
Brendan D. Manning et al.
CELL (2007)
ProTECT: A randomized clinical trial of progesterone for acute traumatic brain injury
David W. Wright et al.
ANNALS OF EMERGENCY MEDICINE (2007)
Therapeutic potential of resveratrol: the in vivo evidence
Joseph A. Baur et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
MGMT: Its role in cancer aetiology and cancer therapeutics
SL Gerson
NATURE REVIEWS CANCER (2004)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Drug repositioning: Identifying and developing new uses for existing drugs
TT Ashburn et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Nuclear factor-κB:: its role in health and disease
A Kumar et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2004)
Induction of the DNA repair gene O6-methylguanine-DNA methyltransferase by dexamethasone in glioblastomas
S Ueda et al.
JOURNAL OF NEUROSURGERY (2004)
Silencing effect of CpG island hypermethylation and histone modifications on O6-methylguanine-DNA methyltransferase (MGMT) gene expression in human cancer
T Nakagawachi et al.
ONCOGENE (2003)
Role of mismatch repair in the induction of chromosomal aberrations and sister chromatid exchanges in cells treated with different chemotherapeutic agents
P Vernole et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2003)
Degradation of the alkylated form of the DNA repair protein, O6-alkylguanine-DNA alkyltransferase
M Xu-Welliver et al.
CARCINOGENESIS (2002)
Aberrant nuclear factor-κB activity and its participation in the growth of human malignant astrocytoma
S Nagai et al.
JOURNAL OF NEUROSURGERY (2002)
Clinical relevance of MGMT in the treatment of cancer
SL Gerson
JOURNAL OF CLINICAL ONCOLOGY (2002)
NF-kappa B at the crossroads of life and death
M Karin et al.
NATURE IMMUNOLOGY (2002)
Further characterization of the helicase activity of eIF4A - Substrate specificity
GW Rogers et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Expression of nuclear factor-κB, tumor necrosis factor receptor type 1, and c-Myc in human astrocytomas
S Hayashi et al.
NEUROLOGIA MEDICO-CHIRURGICA (2001)
Regulation of β-catenin signaling in the Wnt pathway
A Kikuchi
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Share Paper
